FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

327423004: Ferrocontin Continus 562.5mg m/r tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    466908014 Ferrocontin Continus 562.5mg m/r tablet en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    1191467011 Ferrocontin Continus 562.5mg m/r tablet (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Ferrocontin Continus 562.5mg m/r tablet Is a Ferrous glycine sulfate 562.5mg m/r tablet false Inferred relationship Some
    Ferrocontin Continus 562.5mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. sporstoftilskud false Inferred relationship Some
    Ferrocontin Continus 562.5mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Iron false Inferred relationship Some
    Ferrocontin Continus 562.5mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ferrous glycine sulfate (substance) false Inferred relationship Some
    Ferrocontin Continus 562.5mg m/r tablet Is a ferroglycinsulfat 562,5 mg tablet med modificeret udløsning false Inferred relationship Some
    Ferrocontin Continus 562.5mg m/r tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    MOVED TO association reference set

    Back to Start